These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18044144)

  • 1. [Recent topics on diagnosis and therapy for collagen diseases].
    Koike T
    Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2121-3. PubMed ID: 18044144
    [No Abstract]   [Full Text] [Related]  

  • 2. [New concept on diagnosis and therapy for rheumatoid and collagen diseases (discussion)].
    Kumagai S; Yamamoto K; Sagawa A; Nakazawa T; Shane P
    Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2241-61. PubMed ID: 18044162
    [No Abstract]   [Full Text] [Related]  

  • 3. Myasthenia gravis: emerging new therapy options.
    Sieb JP
    Curr Opin Pharmacol; 2005 Jun; 5(3):303-7. PubMed ID: 15907918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.
    Yang T; Nast CC; Vo A; Jordan SC
    Nephrol Dial Transplant; 2008 Jan; 23(1):377-80. PubMed ID: 17981884
    [No Abstract]   [Full Text] [Related]  

  • 5. [New treatments for systemic diseases].
    Bader-Meunier B; Willems M
    Arch Pediatr; 2006 Jun; 13(6):596-8. PubMed ID: 16690273
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic autoimmune hemolytic anemia: toward new treatments?].
    Bader-Meunier B; Leverger G
    Arch Pediatr; 2006 Jun; 13(6):517-9. PubMed ID: 16690295
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuromuscular diseases.
    Kelly JJ
    Rev Neurol Dis; 2008; 5(1):23-6. PubMed ID: 18418319
    [No Abstract]   [Full Text] [Related]  

  • 8. The actual management of pemphigus.
    Daniel BS; Murrell DF
    G Ital Dermatol Venereol; 2010 Oct; 145(5):689-702. PubMed ID: 20930702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal and non-cytotoxic therapies for nephrotic syndrome.
    Coppo R
    Nephrol Dial Transplant; 2008 Jun; 23(6):1793-6. PubMed ID: 18441003
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab, a viable alternative for induction therapy of active lupus nephritis.
    Zhou XJ; Zhao MH; Zhang H
    Rheumatology (Oxford); 2014 Sep; 53(9):1537-8. PubMed ID: 24729446
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of epidermolysis bullosa acquisita.
    Intong LR; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):643-7. PubMed ID: 21925011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.
    Sinha A; Gulati A; Saini S; Blanc C; Gupta A; Gurjar BS; Saini H; Kotresh ST; Ali U; Bhatia D; Ohri A; Kumar M; Agarwal I; Gulati S; Anand K; Vijayakumar M; Sinha R; Sethi S; Salmona M; George A; Bal V; Singh G; Dinda AK; Hari P; Rath S; Dragon-Durey MA; Bagga A;
    Kidney Int; 2014 May; 85(5):1151-60. PubMed ID: 24088957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
    Adams B; Lazarchick J; Medina AM; Willner IR; Neville B; Murphy E; Stuart R; Costa LJ
    Am J Hematol; 2010 Aug; 85(8):627-9. PubMed ID: 20658594
    [No Abstract]   [Full Text] [Related]  

  • 14. [Do biologicals have a place in the treatment of collagen diseases? Pro].
    Lorenz HM
    Dtsch Med Wochenschr; 2009 Sep; 134(36):1764. PubMed ID: 19718598
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of lupus nephritis.
    D'Cruz DP; Hughes GR
    BMJ; 2005 Feb; 330(7488):377-8. PubMed ID: 15718519
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness and safety of rituximab in pemphigus vulgaris].
    Alonso Sánchez A; García Rodríguez S; López Avila A; Rabell Iñigo S
    Farm Hosp; 2010; 34(2):98-9. PubMed ID: 20304370
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment.
    Sánchez-Escuredo A; Núñez R; Ibernón M; Martínez E; López D; Navarro M; Bonet J; Ara J; Romero R
    Nefrologia; 2011; 31(4):502-4. PubMed ID: 21738261
    [No Abstract]   [Full Text] [Related]  

  • 18. PML and rheumatology: the contribution of disease and drugs.
    Molloy ES
    Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S28-32. PubMed ID: 22123931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating immunobullous diseases: an update.
    Reynaert S; Black MM
    Dermatol Nurs; 2004 Feb; 16(1):29-34, 70. PubMed ID: 15022502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring new territory: considering the future.
    Schneider M
    Lupus; 2007; 16(3):221-6. PubMed ID: 17432111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.